UK MHRA to launch consultation on access scheme to unlicensed drugs
This article was originally published in SRA
The UK Medicines and Healthcare products Regulatory Agency is expected to launch shortly a public consultation on implementing its much-awaited scheme for allowing patients to have access to promising new medicines before they are licensed for marketing.
You may also be interested in...
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.